🇺🇸 FDA
Patent

US 9956247

Method of treating lysosomal storage diseases

granted A61KA61K35/28A61K38/46

Quick answer

US patent 9956247 (Method of treating lysosomal storage diseases) held by Sangamo Therapeutics, Inc. expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K35/28, A61K38/46, A61K38/465, A61K48/00